GE HealthCare has secured CE mark approval for its Omni 128cm total body positron emission tomography/computed tomography system, designed to advance cancer diagnosis, staging and therapeutic planning through enhanced molecular imaging capabilities. The next-generation platform addresses growing demand for whole-body PET/CT imaging as global cancer rates are projected to increase 77 per cent by 2050.
The 2nd Annual Hematology-Oncology Pharmacy Summit (HOPS 2026) is set to take place on 16–17 January 2026 at Conrad Dubai, bringing together oncology pharmacists, clinicians, researchers, and industry leaders from across the Middle East and beyond. The Summit aims to drive clinical excellence, collaborative care, and innovation in cancer pharmacotherapy.
A unified computational framework developed at Carnegie Mellon University enables clinicians to analyse all major epileptic biomarkers within a single system, potentially transforming presurgical evaluation for drug-resistant epilepsy patients. The spatial-temporal-spectral imaging approach achieves localisation accuracy within millimetres of invasive monitoring whilst eliminating the need for separate analysis pipelines.
Researchers have developed CytoDiffusion, a diffusion-based generative classifier that surpasses clinical experts in blood cell image analysis. The system demonstrates remarkable capabilities in anomaly detection, uncertainty quantification and domain adaptation whilst generating synthetic images indistinguishable from real samples.
Siemens Healthineers has introduced Optiq AI, an artificial intelligence-powered imaging chain designed to enhance image quality whilst maintaining low radiation doses during image-guided interventional procedures. The technology was presented at the Radiological Society of North America (RSNA) Annual Meeting in Chicago.
Researchers have identified five fundamental genetic factors that explain the majority of genetic risk across 14 psychiatric conditions, based on DNA data from over one million people. The findings challenge current diagnostic boundaries and suggest psychiatric disorders arise from shared biological pathways that manifest differently across conditions, potentially informing more targeted therapeutic development.
A groundbreaking global study reveals that intimate partner violence and sexual violence against children rank among the top health threats worldwide, contributing to over 50 million disability-adjusted life years annually. The research fundamentally challenges persistent views of these forms of violence as primarily social issues, positioning them instead as critical public health priorities demanding immediate, […]
Medical technology start-ups face mounting pressure to navigate complex regulatory frameworks whilst maintaining innovation momentum, according to a newly published white paper from TÜV SÜD. The document, released today, provides structured guidance for young companies seeking to avoid common compliance pitfalls that can delay market entry by months.
Royal Philips has introduced BlueSeal Horizon, the world’s first helium-free 3.0T MRI platform, combining advanced artificial intelligence capabilities with sustainable magnet technology. The system was unveiled at RSNA 2025 in Chicago, representing what the company describes as a major scientific achievement in magnetic resonance imaging.
Hologic has announced expanded CE marking for its Genius Digital Diagnostics System in the European Union, enabling the platform to image and review both cell and tissue specimens. The approval represents a significant expansion from the system’s previous CE marking, which was limited to cell analysis applications such as cervical cancer screening.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
